Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Elisenda Llabrés"'
Autor:
Jaime Feliu, Enrique Espinosa, Laura Basterretxea, Irene Paredero, Elisenda Llabrés, Beatriz Jiménez-Munárriz, Maite Antonio-Rebollo, Beatriz Losada, Alvaro Pinto, Ana Belén Custodio, María del Mar Muñoz, Jenifer Gómez-Mediavilla, María-Dolores Torregrosa, Gema Soler, Patricia Cruz, Oliver Higuera, María-José Molina-Garrido
Publikováno v:
Cancers, Vol 14, Iss 1, p 127 (2021)
Purpose: To identify risk factors for toxicity, unplanned hospitalization (UH) and early death (ED) in older patients with colorectal carcinoma (CRC) initiating chemotherapy. Methods: 215 patients over 70 years were prospectively included. Geriatric
Externí odkaz:
https://doaj.org/article/f2c3f4fd4a434717a6d5d678d54a68e8
Autor:
Jaime Feliu, Alvaro Pinto, Laura Basterretxea, Borja López-San Vicente, Irene Paredero, Elisenda Llabrés, Beatriz Jiménez-Munárriz, Maite Antonio-Rebollo, Beatriz Losada, Enrique Espinosa, Regina Gironés, Ana Belén Custodio, María del Mar Muñoz, Mariana Díaz-Almirón, Jenifer Gómez-Mediavilla, María Dolores Torregrosa, Gema Soler, Patricia Cruz, Oliver Higuera, Juan Ignacio González-Montalvo, María José Molina-Garrido
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 8, p 1615 (2021)
Background: Estimation of life expectancy in older patients is relevant to select the best treatment strategy. We aimed to develop and validate a score to predict early mortality in older patients with cancer. Patients and Methods: A total of 749 pat
Externí odkaz:
https://doaj.org/article/dec82369e24346948956c24229cd658e
Autor:
Jaime Feliu, Enrique Espinosa, Laura Basterretxea, Irene Paredero, Elisenda Llabrés, Beatriz Jiménez-Munárriz, Beatriz Losada, Alvaro Pinto, Ana Belén Custodio, María del Mar Muñoz, Jeniffer Gómez-Mediavilla, María Dolores Torregrosa, Patricia Cruz, Oliver Higuera, María José Molina-Garrido
Publikováno v:
Cancers, Vol 13, Iss 6, p 1437 (2021)
Purpose: To determine the incidence of unplanned hospitalization (UH) and to identify risk factors for UH in elderly patients with cancer who start chemotherapy. Methods: In all, 493 patients over 70 years starting new chemotherapy regimens were pros
Externí odkaz:
https://doaj.org/article/b8bb6de168d84439ab04703932ab8183
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jaime Feliu, Enrique Espinosa, Laura Basterretxea, Irene Paredero, Elisenda Llabrés, Beatriz Jiménez-Munárriz, Maite Antonio-Rebollo, Beatriz Losada, Alvaro Pinto, Ana Belén Custodio, María del Mar Muñoz, Jenifer Gómez-Mediavilla, María-Dolores Torregrosa, Gema Soler, Patricia Cruz, Oliver Higuera, María-José Molina-Garrido
Publikováno v:
Cancers, Vol 14, Iss 127, p 127 (2022)
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers; Volume 14; Issue 1; Pages: 127
Cancers
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers; Volume 14; Issue 1; Pages: 127
Cancers
Simple Summary Chemotoxicity, unplanned hospitalizations (Uhs) and early death (ED) are common among older patients with cancer who receive chemotherapy. Our objective was to determine factors predicting these complications. A predictive score for th
Autor:
Laura Basterretxea, Gema Soler, María Dolores Torregrosa, Alvaro Pinto, Oliver Higuera, Maite Antonio-Rebollo, Patricia Cruz, Enrique Espinosa, J. Feliu, María José Molina-Garrido, Irene Paredero, Beatriz Losada, Ana Custodio, María del Mar Muñoz, Elisenda Llabrés, Jenifer Gómez-Mediavilla, Beatriz Jimenez-Munarriz, Regina Gironés
Publikováno v:
Journal of Geriatric Oncology. 12:381-387
Background Inconsistent doses and schemes are commonly used in older patients receiving cancer chemotherapy. We performed this study in patients with cancer and age ≥ 70 years to determine the frequency of undertreatment and overtreatment as well a
Autor:
Ana Alicia Tejera Hernández, Manuel Cazorla Betancor, Mónica Cejuela Solís, Elena Vicente Rubio, Avinash Ramchandani Vaswani, Jose Lopez, Concepción Jiménez Medina, Pedro Pérez Correa, Paula Junquera Rionda, Isabel Reyes Rodriguez, Marta Pavcovich, Alfonso Gómez de Liaño, Maria Eugenia Galan Garcia, Elisenda Llabrés Valenti, Joel Joselito Aranda Sánchez, Víctor Vega Benítez
Publikováno v:
Cancer Research. 81:PS3-11
Background: Pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) has been reported as a surrogate endpoint for prediction of disease-free survival (DFS) and overall survival (OS) particularly in HER2-positive and triple-negative
Autor:
Jeniffer Gómez-Mediavilla, Alvaro Pinto, Oliver Higuera, Mariana Díaz-Almirón, María Del Mar Muñoz, Jaime Feliu, Maite Antonio-Rebollo, Ana Custodio, Elisenda Llabrés, Beatriz Losada, Gema Soler, Regina Gironés, Laura Basterretxea, María José Molina-Garrido, Beatriz Jimenez-Munarriz, María-Dolores Torregrosa, Enrique Espinosa, Patricia Cruz, Irene Paredero
Publikováno v:
Oncologist
Background Standard oncology tools are inadequate to distinguish which older patients are at higher risk of developing chemotherapy-related complications. Materials and Methods Patients over 70 years of age starting new chemotherapy regimens were pro
Autor:
Encarnación González Flores, Alicia Quílez Cutillas, Alejandro González, Salvador Gámez Casado, Marta Amérigo Góngora, Javier Salvador Bofill, Maria Carmen Álamo de la Gala, Carlos José Rodríguez González, Josefina Cruz Jurado, Pedro Sánchez Rovira, Rocío Urbano Cubero, Rocío Álvarez Ambite, Elisenda Llabrés Valenti, Maria Valero Arbizu, Fernando Henao Carrasco, Manuel Ruiz Borrego, Antonia Martínez Guisado
Publikováno v:
Cancer Research. 80:P1-18
Background: Pertuzumab (P) has been aproved in neoadjuvant setting for HER2 positive early breasta cancer patients in association with Trastuzumab (T) and chemotherapy. Diverse studies support this combination as NeoSphere, Tryphaena, GeparSepto or B
Autor:
Ana Custodio, Patricia Cruz, Elisenda Llabrés, Jaime Feliu, Beatriz Losada, Enrique Espinosa, María Dolores Torregrosa, María José Molina-Garrido, Jeniffer Gómez-Mediavilla, María del Mar Muñoz, Alvaro Pinto, Oliver Higuera, Irene Paredero, Laura Basterretxea, Beatriz Jimenez-Munarriz
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
instname
Cancers
Volume 13
Issue 6
Biblos-e Archivo. Repositorio Institucional de la UAM
Cancers, Vol 13, Iss 1437, p 1437 (2021)
instname
Cancers
Volume 13
Issue 6
Biblos-e Archivo. Repositorio Institucional de la UAM
Cancers, Vol 13, Iss 1437, p 1437 (2021)
Purpose: To determine the incidence of unplanned hospitalization (UH) and to identify risk factors for UH in elderly patients with cancer who start chemotherapy. Methods: In all, 493 patients over 70 years starting new chemotherapy regimens were pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a8a5558429c82e12cb7d1dc9c7979f0
https://hdl.handle.net/20.500.12530/54342
https://hdl.handle.net/20.500.12530/54342